跳至主要内容
临床试验/ISRCTN10626053
ISRCTN10626053
已完成
不适用

se of proteomics to differentiate between benign and potentially malignant pancreatic cystic neoplasms: a pilot study

Geneva University Hospital (Switzerland)0 个研究点目标入组 10 人2010年6月10日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
Geneva University Hospital (Switzerland)
入组人数
10
状态
已完成
最后更新
11年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2010年6月10日
结束日期
待定
最后更新
11年前
研究类型
Observational
性别
All

研究者

发起方
Geneva University Hospital (Switzerland)

入排标准

入选标准

  • 1\. Patients with pancreatic cystic neoplasms as demonstrated by CT scan planned for open surgery
  • 2\. Each patient gave his/her informed consent before surgery

排除标准

  • 1\. Age \< 18 years old
  • 2\. Pregnant women

结局指标

主要结局

未指定

相似试验

已完成
不适用
Identifying protein profile differences between laryngeal cancer of young and elderly patients: a pilot study.cancer of the voice boxlaryngeal cancer1003866610029107
NL-OMON40763niversitair Medisch Centrum Groningen (UMCG)20
已完成
不适用
Proteomic analysis for establishing a biomarker panel for the onset of Adult T-cell Leukemia (ATL)
JPRN-UMIN000038467niversity of the Ryukyus85
已完成
不适用
Study of proteomics for identification of novel prognostic biomarkers in patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma undergoing surgical resectioHepatocellular carcinoma and Intrahepatic cholangiocarcinomaHepatocellular carcinoma, Intrahepatic cholangiocarcinoma, Biomarkers, Proteomics, Prognosis
TCTR20220113002Ratchadapisek Research Funds115
尚未招募
不适用
Application of proteomics to aid biomarker discovery in smear positive patients of P.vivax and P.falciparum malaria
CTRI/2010/091/000451Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT), Powai, Mumbai- 400 076100
进行中(未招募)
不适用
Evaluación mediante proteómica de biomarcadores proteicos asociados con el tratamiento con Eplerenona versus espironolactona en pacientes post-infarto agudo de miocardio, diabéticos con hipertensión arterial no controlada y disfunción ventricular sistólica leve”Identification of proteomic biomarkers associated with eplerenone treatment versus spironolactone in post-acute coronary syndrome patients, with non-controlled arterial hypertension and ventricular dysfunction - PROMETEODisfunción ventricular leve-moderada post-infarto agudo de miocardio en pacientes diabéticos con hipertensión arterial no controlada.Low-moderate ventricular dysfunction in post-acute coronary syndrome patients with diabetes and non-controlled arterial hypertension.
EUCTR2008-001192-29-ESFundación Investigación y Desarrollo en el Area Cardiovascular